Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Gonorrhea Figures

This web page is archived for historical purposes and is no longer being updated.

thumbnail of Figure 14Figure 14. Gonorrhea—Rates, United States, 1941–2010

thumbnail of Figure 15Figure 15. Gonorrhea—Rates by Sex, United States, 1990–2010

thumbnail of Figure 16Figure 16. Gonorrhea—Rates by Region, United States, 2001–2010

thumbnail of Figure 17Figure 17. Gonorrhea—Rates by State, United States and Outlying Areas, 2010

thumbnail of Figure 18Figure 18. Gonorrhea—Rates by County, United States, 2010

thumbnail of Figure 19Figure 19. Gonorrhea—Rates by Age and Sex, United States, 2010

thumbnail of Figure 20Figure 20. Gonorrhea—Rates by Age Among Women Aged 15–44 Years, United States, 2001–2010

thumbnail of Figure 21Figure 21. Gonorrhea—Rates by Age Among Men Aged 15–44 Years, United States, 2001–2010

thumbnail of Figure 22Figure 22. Gonorrhea—Rates by Race/Ethnicity, United States, 2001–2010

thumbnail of Figure 23Figure 23. Gonorrhea—Cases by Reporting Source and Sex, United States, 2001–2010

thumbnail of Figure 24Figure 24. Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2010

thumbnail of Figure 25Figure 25. STD Surveillance Network (SSuN) —Proportion of MSM, MSW, and Women Among Interviewed Gonorrhea Cases by Site, 2010

thumbnail of Figure 26Figure 26. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2010

thumbnail of Figure 27Figure 27. Gonococcal Isolate Surveillance Project (GISP)—Location of Participating Sentinel Sites and Regional Laboratories, United States, 2010

thumbnail of Figure 28Figure 28. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Ceftriaxone Among GISP Isolates, 2006–2010

thumbnail of Figure 29Figure 29. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Cefixime Among GISP Isolates, 2006 and 2009–2010

thumbnail of Figure 30Figure 30. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Azithromycin Among GISP Isolates, 2006–2010

thumbnail of Figure 31Figure 31. Gonococcal Isolate Surveillance Project (GISP)—Percentage of Neisseria gonorrhoeae Isolates with Resistance or Intermediate Resistance to Ciprofloxacin, 1990–2010

thumbnail of Figure 32Figure 32. Gonococcal Isolate Surveillance Project (GISP)—Penicillin, Tetracycline, and Ciprofloxacin Resistance Among GISP Isolates, 2010

thumbnail of Figure 33Figure 33. Gonococcal Isolate Surveillance Project (GISP)—Drugs Used to Treat Gonorrhea Among GISP Participants, 1988–2010



 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30329-4027
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO